Lucila de Campos1, Clóvis Eduardo Santos Galvão1, Eliane Conti Mairena2, Richard Voegels3, Jorge Kalil1,2,4, Fábio Morato Castro1,4, Edécio Cunha-Neto5,6,7. 1. Division of Clinical Immunology and Allergy, Department of Medicine, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455 s. 3207, Sao Paulo, SP, 01246-000, Brazil. 2. Laboratory of Immunology, Instituto do Coração (Incor) Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, SP, Brazil. 3. Division of Otorhinolaryngology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, São Paulo, SP, Brazil. 4. Institute of Investigation in Immunology (iii), INCT, São Paulo, Brazil. 5. Division of Clinical Immunology and Allergy, Department of Medicine, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455 s. 3207, Sao Paulo, SP, 01246-000, Brazil. edecunha@gmail.com. 6. Laboratory of Immunology, Instituto do Coração (Incor) Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, SP, Brazil. edecunha@gmail.com. 7. Institute of Investigation in Immunology (iii), INCT, São Paulo, Brazil. edecunha@gmail.com.
Abstract
PURPOSE: The pathogenesis of persistent allergic rhinitis with chronic and refractory nasal obstruction is still unknown. Inflammation and tissue remodeling are known to play a role, but this has not been studied thoroughly. The purpose of this study is to identify the profile of gene expression of inflammatory and remodeling markers in nasal mucosa of patients with PAR and chronic obstruction. METHODS: After informed consent, we obtained nasal mucosa tissue from five aeroallergen-sensitized PAR patients undergoing anterior turbinectomy, and control non-sensitized individuals undergoing cerebrospinal fluid fistula repair or rhinoplasty. We assessed the expression of 34 genes related to inflammation and tissue remodeling using the real-time polymerase chain reaction (qPCR) to quantify each mRNA. RESULTS: IL-4 mRNA was upregulated in nasal mucosa of all five patients; CCR3, CCR8 and Eotaxin-2 were upregulated in four out of five patient samples; while IL-5 and IL-13 were upregulated in two of them. TGF-β1 was not upregulated in PAR samples. mRNA from metalloproteinases MMP-7, MMP13 and MMP15 were upregulated in three out of five samples. Our results indicate a typical mRNA expression profile of the infiltrating inflammatory Th2 cells and eosinophils, combined with altered gene expression of remodeling-related proteins in stromal cells from the mucosa. CONCLUSION: Prolonged allergen challenge can lead to persistent upregulation of genes for inflammatory mediators such as IL-4 Th2/eosinophil cytokines, chemokines and receptors, which may play an important role in maintaining PAR with chronic nasal obstruction. Our findings may have therapeutic implications, including the use of anti-IL4, -CCR3 or -MMP therapy to ameliorate the condition.
PURPOSE: The pathogenesis of persistent allergic rhinitis with chronic and refractory nasal obstruction is still unknown. Inflammation and tissue remodeling are known to play a role, but this has not been studied thoroughly. The purpose of this study is to identify the profile of gene expression of inflammatory and remodeling markers in nasal mucosa of patients with PAR and chronic obstruction. METHODS: After informed consent, we obtained nasal mucosa tissue from five aeroallergen-sensitized PAR patients undergoing anterior turbinectomy, and control non-sensitized individuals undergoing cerebrospinal fluid fistula repair or rhinoplasty. We assessed the expression of 34 genes related to inflammation and tissue remodeling using the real-time polymerase chain reaction (qPCR) to quantify each mRNA. RESULTS:IL-4 mRNA was upregulated in nasal mucosa of all five patients; CCR3, CCR8 and Eotaxin-2 were upregulated in four out of five patient samples; while IL-5 and IL-13 were upregulated in two of them. TGF-β1 was not upregulated in PAR samples. mRNA from metalloproteinases MMP-7, MMP13 and MMP15 were upregulated in three out of five samples. Our results indicate a typical mRNA expression profile of the infiltrating inflammatory Th2 cells and eosinophils, combined with altered gene expression of remodeling-related proteins in stromal cells from the mucosa. CONCLUSION: Prolonged allergen challenge can lead to persistent upregulation of genes for inflammatory mediators such as IL-4 Th2/eosinophil cytokines, chemokines and receptors, which may play an important role in maintaining PAR with chronic nasal obstruction. Our findings may have therapeutic implications, including the use of anti-IL4, -CCR3 or -MMP therapy to ameliorate the condition.
Authors: Thomas J Richards; Chunghyun Park; Yiliang Chen; Kevin F Gibson; Y Peter Di; Annie Pardo; Simon C Watkins; Augustine M K Choi; Moises Selman; Joseph Pilewski; Naftali Kaminski; Yingze Zhang Journal: Am J Physiol Lung Cell Mol Physiol Date: 2012-01-20 Impact factor: 5.464
Authors: R U Pawankar; M Okuda; S Hasegawa; K Suzuki; H Yssel; K Okubo; K Okumura; C Ra Journal: Am J Respir Crit Care Med Date: 1995-12 Impact factor: 21.405
Authors: Philippe Eloy; Anne Lise Poirrier; Clotilde De Dorlodot; Thibaut Van Zele; Jean Baptiste Watelet; Bernard Bertrand Journal: Curr Allergy Asthma Rep Date: 2011-04 Impact factor: 4.806